ml 7 has been researched along with Glaucoma, Suspect in 1 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, RL | 1 |
| Kahraman, M | 1 |
| Prins, TJ | 1 |
| Beaver, Y | 1 |
| Cook, TG | 1 |
| Cramp, J | 1 |
| Cayanan, CS | 1 |
| Gardiner, EM | 1 |
| McLaughlin, MA | 1 |
| Clark, AF | 1 |
| Hellberg, MR | 1 |
| Shiau, AK | 1 |
| Noble, SA | 1 |
| Borchardt, AJ | 1 |
1 other study available for ml 7 and Glaucoma, Suspect
| Article | Year |
|---|---|
Benzothiophene containing Rho kinase inhibitors: Efficacy in an animal model of glaucoma.
Topics: Animals; Disease Models, Animal; Glaucoma; Haplorhini; HeLa Cells; Humans; Intraocular Pressure; Ocu | 2010 |